613450 Sigma-AldrichTOFA - CAS 54857-86-2 - Calbiochem
A cell-permeable furoic acid compound that acts as a potent, reversible, and competitive inhibitor of acetyl-CoA carboxylase (ACC), a key enzyme involved in the fatty acid biosynthesis.
More>> A cell-permeable furoic acid compound that acts as a potent, reversible, and competitive inhibitor of acetyl-CoA carboxylase (ACC), a key enzyme involved in the fatty acid biosynthesis. Less<<TOFA - CAS 54857-86-2 - Calbiochem: SDB (Sicherheitsdatenblätter), Analysenzertifikate und Qualitätszertifikate, Dossiers, Broschüren und andere verfügbare Dokumente.
Synonyme: 5-(Tetradecyloxy)-2-furoic acid
Empfohlene Produkte
Übersicht
| Replacement Information |
|---|
Key Spec Table
| CAS # | Empirical Formula |
|---|---|
| 54857-86-2 | C₁₉H₃₂O₄ |
Preis & Verfügbarkeit
| Bestellnummer | Verfügbarkeit | Verpackung | St./Pkg. | Preis | Menge | |
|---|---|---|---|---|---|---|
| 613450-5MG |
|
Kst.-Ampulle | 5 mg |
|
— |
| Description | |
|---|---|
| Overview | A cell-permeable furoic acid compound that acts as a potent, reversible, and competitive inhibitor of acetyl-CoA carboxylase (ACC), a key enzyme involved in the fatty acid biosynthesis. Inhibits cellular fatty acid synthesis in a dose-dependent manner (IC50 = 4 µM in human breast cancer cell line MCF7). TOFA-induced reduction in malonyl-CoA is reported to off-set the effect of C75 (Cat. No. 341325) on food intake in fasted mice and on apoptosis in tumor cells. |
| Catalogue Number | 613450 |
| Brand Family | Calbiochem® |
| Synonyms | 5-(Tetradecyloxy)-2-furoic acid |
| Product Information | |
|---|---|
| CAS number | 54857-86-2 |
| ATP Competitive | Y |
| Form | Off-white solid |
| Hill Formula | C₁₉H₃₂O₄ |
| Chemical formula | C₁₉H₃₂O₄ |
| Reversible | Y |
| Structure formula Image | |
| Quality Level | MQ100 |
| Applications |
|---|
| Biological Information | |
|---|---|
| Primary Target | Acetyl-CoA carboxylase (ACC) |
| Primary Target IC<sub>50</sub> | 4 µM inhibiting cellular fatty acid synthesis in human breast cancer cell line MCF7 |
| Purity | ≥98% by HPLC |
| Physicochemical Information | |
|---|---|
| Cell permeable | Y |
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS |
|---|
| Safety Information |
|---|
| Product Usage Statements |
|---|
| Packaging Information | |
|---|---|
| Packaged under inert gas | Packaged under inert gas |
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade Item Number | |
|---|---|
| Bestellnummer | GTIN |
| 613450-5MG | 04055977263787 |
Documentation
TOFA - CAS 54857-86-2 - Calbiochem SDB
| Titel |
|---|
TOFA - CAS 54857-86-2 - Calbiochem Analysenzertifikate
| Titel | Chargennummer |
|---|---|
| 613450 |
Literatur
| Übersicht |
|---|
| Landree, L.E., et al. 2004. J. Biol. Chem. 279, 3817. Zhou, W., et al. 2003. Cancer Res. 63, 7330. Hu, Z., et al. 2003. Proc. Natl. Acad. Sci. USA 100, 12624. Pizer, E.S., et al. 2000. Cancer Res. 60, 213. Arbeeny, C.M., et al. 1992. J. Lipid Res. 33, 843. Fukuda, N. and Ontko, J.A. 1984. J. Lipid Res. 25, 831. |